Aztreonam (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Aztreonam" in Indonesian language version.

Last modified: 13:37:15, 14 July 2026 (UTC)

Ref.Un. Ref.Website

Global rank Indonesian rank

1010nih.gov

5^th place

6^th place

77doi.org

2^nd place

51drugs.com

529^th place

177^th place

43archive.org

6^th place

3^rd place

33web.archive.org

1^st place

22hdl.handle.net

66^th place

122^nd place

22toku-e.com

low place

22clinicaltrials.gov

4,259^th place

5,190^th place

22businessweek.com

945^th place

411^th place

11worldcat.org

4^th place

5^th place

11books.google.com

3^rd place

4^th place

11semanticscholar.org

15^th place

26^th place

archive.org (Global: 6^th place; Indonesian: 3^rd place)

British national formulary : BNF 69 (Edisi 69). British Medical Association. 2015. hlm. 381. ISBN 9780857111562.
Johnson DH, Cunha BA (1995). "Aztreonam". Medical Clinics of North America (dalam bahasa Inggris). 79 (4): 733–743. doi:10.1016/S0025-7125(16)30036-0. PMID 7791420.
AHFS Drug Information 2006 (Edisi 2006). American Society of Health-System Pharmacists. 2006.

books.google.com (Global: 3^rd place; Indonesian: 4^th place)

Yaffe SJ, Aranda JV (2010). Neonatal and Pediatric Pharmacology: Therapeutic Principles in Practice. Lippincott Williams & Wilkins. hlm. 438. ISBN 9780781795388.

businessweek.com (Global: 945^th place; Indonesian: 411^th place)

Catherine L (22 Februari 2010). "Gilead's Inhaled Antibiotic for Lungs Wins Approval". BusinessWeek. Diarsipkan dari asli tanggal 2 Maret 2010. Diakses tanggal 5 Maret 2010.{{cite news}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"FDA approves Gilead cystic fibrosis drug Cayston". BusinessWeek. 23 Februari 2010. Diarsipkan dari asli tanggal 1 Maret 2010. Diakses tanggal 5 Maret 2010.{{cite news}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

clinicaltrials.gov (Global: 4,259^th place; Indonesian: 5,190^th place)

Nomor uji klinis NCT03329092 for "A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. (REVISIT)" di ClinicalTrials.gov
Nomor uji klinis NCT03580044 for "Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria" di ClinicalTrials.gov

doi.org (Global: 2^nd place; Indonesian: 2^nd place)

Quon BS, Goss CH, Ramsey BW (Maret 2014). "Inhaled antibiotics for lower airway infections". Annals of the American Thoracic Society. 11 (3): 425–34. doi:10.1513/annalsats.201311-395fr. PMC 4028738. PMID 24673698.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Kobayashi Y, Uchida H, Kawakami Y (Desember 1992). "Synergy with aztreonam and arbekacin or tobramycin against Pseudomonas aeruginosa isolated from blood". The Journal of Antimicrobial Chemotherapy. 30 (6): 871–2. doi:10.1093/jac/30.6.871. PMID 1289363.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
James CW, Gurk-Turner C (Januari 2001). "Cross-reactivity of beta-lactam antibiotics". Proceedings. 14 (1): 106–107. doi:10.1080/08998280.2001.11927741. PMC 1291320. PMID 16369597.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Johnson DH, Cunha BA (1995). "Aztreonam". Medical Clinics of North America (dalam bahasa Inggris). 79 (4): 733–743. doi:10.1016/S0025-7125(16)30036-0. PMID 7791420.
Mauri C, Maraolo AE, Di Bella S, Luzzaro F, Principe L (Agustus 2021). "The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases". Antibiotics. 10 (8): 1012. doi:10.3390/antibiotics10081012. PMC 8388901. PMID 34439062.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Di Bella S, Sanson G, Monticelli J, Zerbato V, Principe L, Giuffrè M, Pipitone G, Luzzati R (Februari 2024). Staley C, Abhyankar M (ed.). "Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options". Clinical Microbiology Reviews: e0013523. doi:10.1128/cmr.00135-23. PMID 38421181.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Terico AT, Gallagher JC (Desember 2014). "Beta-lactam hypersensitivity and cross-reactivity". Journal of Pharmacy Practice. 27 (6): 530–544. doi:10.1177/0897190014546109. PMID 25124380. S2CID 19275020.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

drugs.com (Global: 529^th place; Indonesian: 177^th place)

"Aztreonam". The American Society of Health-System Pharmacists. Diakses tanggal 8 Desember 2017.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

hdl.handle.net (Global: 66^th place; Indonesian: 122^nd place)

World Health Organization (2019). Executive summary: the selection and use of essential medicines 2019: report of the 22nd WHO Expert Committee on the selection and use of essential medicines. Geneva: World Health Organization. hdl:10665/325773. WHO/MVP/EMP/IAU/2019.05. License: CC BY-NC-SA 3.0 IGO.
World Health Organization (2019). The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2019 (including the 21st WHO Model List of Essential Medicines and the 7th WHO Model List of Essential Medicines for Children). Geneva: World Health Organization. hdl:10665/330668. ISBN 9789241210300. ISSN 0512-3054. WHO technical report series;1021.

nih.gov (Global: 5^th place; Indonesian: 6^th place)

pubmed.ncbi.nlm.nih.gov

Quon BS, Goss CH, Ramsey BW (Maret 2014). "Inhaled antibiotics for lower airway infections". Annals of the American Thoracic Society. 11 (3): 425–34. doi:10.1513/annalsats.201311-395fr. PMC 4028738. PMID 24673698.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Kobayashi Y, Uchida H, Kawakami Y (Desember 1992). "Synergy with aztreonam and arbekacin or tobramycin against Pseudomonas aeruginosa isolated from blood". The Journal of Antimicrobial Chemotherapy. 30 (6): 871–2. doi:10.1093/jac/30.6.871. PMID 1289363.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
James CW, Gurk-Turner C (Januari 2001). "Cross-reactivity of beta-lactam antibiotics". Proceedings. 14 (1): 106–107. doi:10.1080/08998280.2001.11927741. PMC 1291320. PMID 16369597.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Johnson DH, Cunha BA (1995). "Aztreonam". Medical Clinics of North America (dalam bahasa Inggris). 79 (4): 733–743. doi:10.1016/S0025-7125(16)30036-0. PMID 7791420.
Mauri C, Maraolo AE, Di Bella S, Luzzaro F, Principe L (Agustus 2021). "The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases". Antibiotics. 10 (8): 1012. doi:10.3390/antibiotics10081012. PMC 8388901. PMID 34439062.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Di Bella S, Sanson G, Monticelli J, Zerbato V, Principe L, Giuffrè M, Pipitone G, Luzzati R (Februari 2024). Staley C, Abhyankar M (ed.). "Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options". Clinical Microbiology Reviews: e0013523. doi:10.1128/cmr.00135-23. PMID 38421181.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Terico AT, Gallagher JC (Desember 2014). "Beta-lactam hypersensitivity and cross-reactivity". Journal of Pharmacy Practice. 27 (6): 530–544. doi:10.1177/0897190014546109. PMID 25124380. S2CID 19275020.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

ncbi.nlm.nih.gov

Quon BS, Goss CH, Ramsey BW (Maret 2014). "Inhaled antibiotics for lower airway infections". Annals of the American Thoracic Society. 11 (3): 425–34. doi:10.1513/annalsats.201311-395fr. PMC 4028738. PMID 24673698.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
James CW, Gurk-Turner C (Januari 2001). "Cross-reactivity of beta-lactam antibiotics". Proceedings. 14 (1): 106–107. doi:10.1080/08998280.2001.11927741. PMC 1291320. PMID 16369597.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Mauri C, Maraolo AE, Di Bella S, Luzzaro F, Principe L (Agustus 2021). "The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases". Antibiotics. 10 (8): 1012. doi:10.3390/antibiotics10081012. PMC 8388901. PMID 34439062.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

semanticscholar.org (Global: 15^th place; Indonesian: 26^th place)

api.semanticscholar.org

Terico AT, Gallagher JC (Desember 2014). "Beta-lactam hypersensitivity and cross-reactivity". Journal of Pharmacy Practice. 27 (6): 530–544. doi:10.1177/0897190014546109. PMID 25124380. S2CID 19275020.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

toku-e.com (Global: low place; Indonesian: low place)

"Aztreonam Susceptibility and Minimum Inhibitory Concentration (MIC) Data" (PDF). toku-e.com. 3 Februari 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"Aztreonam spectrum of bacterial susceptibility and Resistance" (PDF). Product Data Sheet. toku-e.com. Diarsipkan dari asli (PDF) tanggal 27 Maret 2014. Diakses tanggal 15 Mei 2012.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

web.archive.org (Global: 1^st place; Indonesian: 1^st place)

"Aztreonam spectrum of bacterial susceptibility and Resistance" (PDF). Product Data Sheet. toku-e.com. Diarsipkan dari asli (PDF) tanggal 27 Maret 2014. Diakses tanggal 15 Mei 2012.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Catherine L (22 Februari 2010). "Gilead's Inhaled Antibiotic for Lungs Wins Approval". BusinessWeek. Diarsipkan dari asli tanggal 2 Maret 2010. Diakses tanggal 5 Maret 2010.{{cite news}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"FDA approves Gilead cystic fibrosis drug Cayston". BusinessWeek. 23 Februari 2010. Diarsipkan dari asli tanggal 1 Maret 2010. Diakses tanggal 5 Maret 2010.{{cite news}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

worldcat.org (Global: 4^th place; Indonesian: 5^th place)

search.worldcat.org

World Health Organization (2019). The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2019 (including the 21st WHO Model List of Essential Medicines and the 7th WHO Model List of Essential Medicines for Children). Geneva: World Health Organization. hdl:10665/330668. ISBN 9789241210300. ISSN 0512-3054. WHO technical report series;1021.

Aztreonam (Indonesian Wikipedia)

archive.org (Global: 6th place; Indonesian: 3rd place)

books.google.com (Global: 3rd place; Indonesian: 4th place)

businessweek.com (Global: 945th place; Indonesian: 411th place)

clinicaltrials.gov (Global: 4,259th place; Indonesian: 5,190th place)

doi.org (Global: 2nd place; Indonesian: 2nd place)

drugs.com (Global: 529th place; Indonesian: 177th place)

hdl.handle.net (Global: 66th place; Indonesian: 122nd place)

nih.gov (Global: 5th place; Indonesian: 6th place)